Purchases and Sales Made in Q4 2021 in Esperion Therapeutics, Inc. (ESPR)
This table provides information about the institutional ownership of Esperion Therapeutics, Inc. (ESPR) during Q4 2021. The information is specifically focused on institutions that hold shares of Esperion Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2022
Q4 2021
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-56.3K- 21.73% |
$271K - $671K
|
203K
$377K
|
|
Jan 21, 2022
Q4 2021
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-94.5KClosed |
$455K - $1.13M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Cinctive Capital Management LP
New York, NY |
SELL
|
- |
-111KClosed |
$532K - $1.32M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Linden Advisors LP
New York, NY |
SELL
|
- |
-117KClosed |
$562K - $1.39M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-133K- 28.43% |
$639K - $1.58M
|
334K
$622K
|
|
Feb 11, 2022
Q4 2021
|
Sculptor Capital LP
New York, NY |
SELL
|
- |
-133K- 74.08% |
$639K - $1.58M
|
46.5K
$86.5K
|
|
Feb 09, 2022
Q4 2021
|
Lazard Asset Management LLC
New York, NY |
SELL
|
- |
-133K- 78.58% |
$640K - $1.59M
|
36.3K
$67.5K
|
|
Feb 14, 2022
Q4 2021
|
Granahan Investment Management, LLC
Waltham, MA |
SELL
|
- |
-294KClosed |
$1.41M - $3.5M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-520KClosed |
$2.5M - $6.2M
|
0
$0
|